Doebele Robert 4
4 · Rain Oncology Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Doebele Robert
EVP, Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-15+123,325→ 123,325 totalExercise: $9.30Exp: 2033-02-15→ Common Stock (123,325 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 123,325 shares of the Issuer's common stock, one quarter of which will vest on February 15, 2024, with the remaining three quarters vesting in equal monthly installments through February 15, 2027, subject to the Reporting Person's continued service to the Issuer.